Live tape
Top 8, mentions 7d9,388TSLA1,985 mentions▲ +0.05GOOGL1,524 mentions▲ +0.04NVDA1,142 mentions▲ +0.07CRWV1,134 mentions▲ +0.03SPCX1,019 mentions▲ +0.07QQQ992 mentions▲ +0.04META796 mentions▲ +0.05NBIS796 mentions▲ +0.05

Equity · Healthcare

ADMA

NASDAQ

ADMA Biologics, Inc.

$10.69 −0.47% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$11 $8 21 Jul 16 Oct

The line runs $8.60 on 21 July through $10.69 on 16 October, on a scale from $8 to $11. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
Market cap $2.4B
P/E (TTM) 15.3
52-week range $7.59 – $20
Avg volume 243.9K

as of Oct 16, 2026

ADMA insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 24 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
24 Jul 2026 Kestenberg-Messina Kaitlin M. COO and SVP, Compliance Tax withheld 3,177 $27K

ADMA reported financials

SEC EDGAR XBRL SEC EDGAR

ADMA reported revenue of $510.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was $146.9M.

Figure Reported Period
Revenue $510.2M 31 Dec 2025 fiscal year
Net income $146.9M 31 Dec 2025 fiscal year
Diluted EPS $0.60 31 Dec 2025 fiscal year
Total assets $684.2M 30 Jun 2026 at period end
Total equity $408.2M 30 Jun 2026 at period end

ADMA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.16 —
31 Mar 2026 Q1 2026 $0.19 —
31 Dec 2025 FY 2025 $0.60 —
30 Sep 2025 Q3 2025 $0.15 —
30 Jun 2025 Q2 2025 $0.14 —
31 Mar 2025 Q1 2025 $0.11 —
31 Dec 2024 FY 2024 $0.81 —
30 Sep 2024 Q3 2024 $0.15 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ADMA institutional holders

SEC Form 13F SEC EDGAR

12 of the 45 institutional funds we track reported a ADMA position for the quarter ended 30 Jun 2026 — a combined $147.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Added +840.5% shares 5,274,597 $44.1M
Duquesne Family Office Added +80.1% shares 2,784,110 $23.3M
Two Sigma Investments Held (±25%) −3.5% shares 2,019,887 $16.9M
Fundsmith Held (±25%) 1,649,493 $13.8M
AQR Capital Management Added +196.4% shares 1,525,581 $12.8M
Citadel Advisors Trimmed −76.4% shares 1,370,071 $11.5M
Millennium Management Trimmed −66.4% shares 1,154,228 $9.7M
Renaissance Technologies Trimmed −48.3% shares 652,530 $5.5M
Point72 Asset Management Trimmed −87.4% shares 413,935 $3.5M
Bridgewater Associates Held (±25%) −15.0% shares 401,059 $3.4M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SEC EDGARValuation computed from SEC EDGAR filings